SLC16A1-AS1 lncRNA is still abundant even after MCT1 deactivation, thereby theoretically offering cancer cells a selective advantage for evading the tumor suppressing effect of MCT1 inhibitors through enhancement of respiration. Here, SLC16A1 is linked to cancer.